Impacto
Downloads
Downloads per month over past year
Bueno Muiño, Coralia and Martín, Miguel and Monte Millán, María del and García Saénz, José Ángel and López Tarruella, Sara (2022) HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping. Cancers, 14 (3). p. 512. ISSN 2072-6694
Preview |
PDF
Creative Commons Attribution. 323kB |
Official URL: https://doi.org/10.3390/cancers14030512
Abstract
Classical clinical research has been developed according to immunohistochemical breast cancer subtypes, instead of designing trials specifically for each molecular subtype. Efforts in de-escalating treatment should focus on identifying a subgroup of HER2 oncogene addicted tumours that are especially sensitive to anti-HER2 therapies and, thus, spare unnecessary treatments. A prognostic assay that integrates molecular tumour features with clinical and pathologic variables and accurately defines a group of HER2 addicted tumours remains the best candidate among these strategies.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | early; HER2+; escalation; de-escalation; intrinsic subtype; HER2-enriched |
| Subjects: | Medical sciences > Medicine > Oncology |
| ID Code: | 72849 |
| Deposited On: | 16 Jun 2022 16:30 |
| Last Modified: | 17 Jun 2022 07:09 |
Origin of downloads
Repository Staff Only: item control page
